These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 21863614)

  • 41. Personalized medicine in diabetes mellitus: current opportunities and future prospects.
    Kleinberger JW; Pollin TI
    Ann N Y Acad Sci; 2015 Jun; 1346(1):45-56. PubMed ID: 25907167
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pharmacogenetic variation of
    Mousavi S; Kohan L; Yavarian M; Habib A
    Mol Biol Res Commun; 2017 Jun; 6(2):91-94. PubMed ID: 28775995
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Genotypic and Phenotypic Factors Influencing Drug Response in Mexican Patients With Type 2 Diabetes Mellitus.
    Sanchez-Ibarra HE; Reyes-Cortes LM; Jiang XL; Luna-Aguirre CM; Aguirre-Trevino D; Morales-Alvarado IA; Leon-Cachon RB; Lavalle-Gonzalez F; Morcos F; Barrera-Saldaña HA
    Front Pharmacol; 2018; 9():320. PubMed ID: 29681852
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Gene expression signature: a powerful approach for drug discovery in diabetes.
    Sithara S; Crowley TM; Walder K; Aston-Mourney K
    J Endocrinol; 2017 Feb; 232(2):R131-R139. PubMed ID: 27927696
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pharmacogenetics for type 2 diabetes: practical considerations for study design.
    Vella A
    J Diabetes Sci Technol; 2009 Jul; 3(4):705-9. PubMed ID: 20144317
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Personalized therapy for diabetes in retrospect and prospect].
    Tkáč I
    Vnitr Lek; 2014 Sep; 60(9):797-800. PubMed ID: 25294772
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Personalized medicine in Type 2 Diabetes.
    Liao WL; Tsai FJ
    Biomedicine (Taipei); 2014; 4(2):8. PubMed ID: 25520921
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pharmacogenomics of Drug Response in Type 2 Diabetes: Toward the Definition of Tailored Therapies?
    Pollastro C; Ziviello C; Costa V; Ciccodicola A
    PPAR Res; 2015; 2015():415149. PubMed ID: 26161088
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Type 2 diabetes mellitus: Clinical aspects of genetics, nutrigenetics, and pharmacogenetics].
    Ametov AS; Kamynina LL; Akhmedova ZG
    Ter Arkh; 2015; 87(8):124-131. PubMed ID: 28635881
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pharmacogenetics in type 2 diabetes: still a conundrum in clinical practice.
    Brunetti A; Chiefari E; Foti DP
    Expert Rev Endocrinol Metab; 2017 May; 12(3):155-158. PubMed ID: 30063457
    [No Abstract]   [Full Text] [Related]  

  • 51. Pharmacogenetics of oral antidiabetic drugs.
    Becker ML; Pearson ER; Tkáč I
    Int J Endocrinol; 2013; 2013():686315. PubMed ID: 24324494
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Individualized therapy for type 2 diabetes: clinical implications of pharmacogenetic data.
    Mannino GC; Sesti G
    Mol Diagn Ther; 2012 Oct; 16(5):285-302. PubMed ID: 23018631
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Can genetics improve precision of therapy in diabetes?
    Groop L; Storm P; Rosengren A
    Trends Endocrinol Metab; 2014 Sep; 25(9):440-3. PubMed ID: 25028244
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The pharmacogenetics of type 2 diabetes: a systematic review.
    Maruthur NM; Gribble MO; Bennett WL; Bolen S; Wilson LM; Balakrishnan P; Sahu A; Bass E; Kao WH; Clark JM
    Diabetes Care; 2014; 37(3):876-86. PubMed ID: 24558078
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pharmacogenetic variation and metformin response.
    Chen S; Zhou J; Xi M; Jia Y; Wong Y; Zhao J; Ding L; Zhang J; Wen A
    Curr Drug Metab; 2013 Dec; 14(10):1070-82. PubMed ID: 24329113
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evaluation of the effect of MTNR1B rs10830963 gene variant on the therapeutic efficacy of nateglinide in treating type 2 diabetes among Chinese Han patients.
    Song JF; Zhang J; Zhang MZ; Ni J; Wang T; Zhao YQ; Khan NU
    BMC Med Genomics; 2021 Jun; 14(1):156. PubMed ID: 34118937
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Autophagy and its link to type II diabetes mellitus.
    Yang JS; Lu CC; Kuo SC; Hsu YM; Tsai SC; Chen SY; Chen YT; Lin YJ; Huang YC; Chen CJ; Lin WD; Liao WL; Lin WY; Liu YH; Sheu JC; Tsai FJ
    Biomedicine (Taipei); 2017 Jun; 7(2):8. PubMed ID: 28612706
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Use of bedaquiline and delamanid in diabetes patients: clinical and pharmacological considerations.
    Hu M; Zheng C; Gao F
    Drug Des Devel Ther; 2016; 10():3983-3994. PubMed ID: 27994440
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pharmacogenetics and personalized treatment of type 2 diabetes.
    Semiz S; Dujic T; Causevic A
    Biochem Med (Zagreb); 2013; 23(2):154-71. PubMed ID: 23894862
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.